MREO (STOCKS)
Mereo BioPharma Group plc American Depositary Shares
$0.330200
+0.001200 (+0.36%)
Prev close: $0.329000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Denise Vera Scots-Knight
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $50.92M
- Employees
- 36
- P/E (TTM)
- -1.24
- P/B (TTM)
- 1.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
5
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.01 | $-0.01 | +0.0031 | +23.66% |
|
Sep 2025 (Q3)
|
$-0.01 | $-0.02 | +0.0148 | +59.68% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.02 | -0.0833 | -498.80% |
|
Mar 2025 (Q1)
|
$-0.10 | $-0.01 | -0.0926 | -1,251.35% |
Financial Statements
| Revenues | $500.00K |
| Benefits Costs and Expenses | $42.38M |
| Costs And Expenses | $42.38M |
| Operating Expenses | $40.61M |
| Research and Development | $17.77M |
| Other Operating Expenses | $22.84M |
| Operating Income/Loss | -$40.11M |
| Income/Loss From Continuing Operations After Tax | -$41.88M |
| Income/Loss From Continuing Operations Before Tax | -$41.88M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $255.00K |
| Net Income/Loss | -$41.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$41.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$41.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.05 |
| Diluted Earnings Per Share | -$0.05 |
| Basic Average Shares | 797,119,632 |
| Diluted Average Shares | 797,119,632 |
| Assets | $45.92M |
| Current Assets | $45.02M |
| Noncurrent Assets | $897.00K |
| Fixed Assets | $137.00K |
| Other Non-current Assets | $760.00K |
| Liabilities | $5.00M |
| Current Liabilities | $4.30M |
| Accounts Payable | $1.33M |
| Other Current Liabilities | $2.97M |
| Noncurrent Liabilities | $699.00K |
| Equity | $40.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $40.92M |
| Liabilities And Equity | $45.92M |
| Net Cash Flow From Operating Activities | -$30.97M |
| Net Cash Flow From Operating Activities, Continuing | -$30.97M |
| Net Cash Flow From Investing Activities | -$20.00K |
| Net Cash Flow From Investing Activities, Continuing | -$20.00K |
| Net Cash Flow From Financing Activities | $327.00K |
| Net Cash Flow From Financing Activities, Continuing | $327.00K |
| Exchange Gains/Losses | $1.85M |
| Net Cash Flow | -$28.81M |
| Net Cash Flow, Continuing | -$30.66M |
| Comprehensive Income/Loss | -$33.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$33.85M |
| Other Comprehensive Income/Loss | $8.03M |